China National Center for Cardiovascular Diseases clinical trial pipeline
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-19
What changed in the last 30 days
12 trials changed in the last 30 days: 0 stopped, 6 with notable changes, 6 with minor changes only.
-
Minor: 3 trials marked Unknown by the registry's verification sweep Changed
- Minor: Calcium-Phosphorus Regulation Therapy on Heart Valve Disease Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Recruiting
- Minor: Goal Setting and Mobile-based Self-management Tool to Improve Diet Quality · High Blood Pressure Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Recruiting
- Minor: Risk Factors for Stroke or Systemic Embolism · Non-Valvular Atrial Fibrillation Registry Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Recruiting
- Minor: SCOUT · Scalable Clinical Oversight of Large Language Models Via Uncertainty Triangulation Completed without a posted recruiting period
- Minor: Implementation of Machine Learning and Hemodynamic Profiles Based Clinical Decision Support Systems for Personalized Guideline Accordant Antihypertensive Regimens in Primary Care: a Pragmatic Cluster Randomized Controlled Trial Trial completed
- Notable: Vasopressor Agents in Pulmonary Hypertension Crisis Recruitment opened
- Notable: Ultrasound Guided Leadless Pacemaker Implantation Primary endpoint(s) modified
- Notable: Initiation of Tafolecimab · Acute Coronary Syndromeundergoing Percutaneous Coronary Intervention in Chinese Population Primary completion pushed from Nov 1, 2025 to Mar 1, 2028
- Notable: LoDoCo-TAVR · Low-dose Colchicine for Thromboprophylaxis After Transcatheter Aortic Valve Replacement Recruitment opened
- Minor: OCR-LLM-CHD · AI-Assisted Coronary Syndrome Subtyping From Admission History of Present Illness: A Clinician Reader Study Completed without a posted recruiting period
- Notable: PRECISE-AFMR I · Transcatheter Mitral Valve Edge-to-Edge Repair for Atrial Functional Mitral Regurgitation in Patients at High Surgical Risk Recruitment opened
- Notable: SMCs With LVH Compared to HCM Primary completion date changed from estimate of Dec 31, 2025 to Jul 20, 2026
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates
New trial filings, last 30 days
| First posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-11-16 | NCT07938528 Strategy of Intracoronary Imaging Guided Drug-Coated Balloon Therapy for De Novo Lesions… | Not Yet Recruiting | |
| 2026-11-12 | NCT07932145 Early Mineralocorticoid Receptor Antagonist Therapy for Low-Renin Essential Hypertension | Phase 4 | Not Yet Recruiting |
| 2026-11-10 | NCT07927582 Pulsed Field Ablation for Atrial Fibrillation Under General Anesthesia Versus… | Not Yet Recruiting | |
| 2026-11-09 | NCT07926854 Unipolar Voltage-Guided Substrate Modification Plus Pulsed Field Ablation Pulmonary Vein… | Not Yet Recruiting | |
| 2026-11-05 | NCT07918781 Partial Cardiac Denervation for Preventing Atrial Fibrillation After CABG | Not Yet Recruiting | |
| 2026-11-04 | NCT07917078 Reduced-Dose Thrombolysis in Intermediate-Risk Pulmonary Embolism With High-Risk Features | Phase 3 | Not Yet Recruiting |
| 2026-11-04 | NCT07917676 Multimodal AI-Driven Out-of-Hospital Management for Hypertension and Cardiometabolic Risk | Not Yet Recruiting | |
| 2026-11-03 | NCT07912671 Out-Patient Proactive Observation With Wearable-Assisted Tracking for Cardiovascular… | Not Yet Recruiting | |
| 2026-10-27 | NCT07896980 MRI-guided Ventricular Tachycardia Ablation in Patients With Structural Heart Disease | Not Yet Recruiting | |
| 2026-10-23 | NCT07891052 Wearable Ultrasound for Cardiac Monitoring During Surgery and in Intensive Care | Not Yet Recruiting |
Active trials by phase
| Early Phase 1 | 1 | |
| Phase 1 | 1 | |
| Phase 2 | 1 | |
| Phase 3 | 1 | |
| Phase 4 | 19 |
Not charted: 96 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).
Disease areas by active trials
Heart Disease (84) · Coronary Artery Disease (41) · Atrial Fibrillation (16) · Hypertension (12) · Stroke (9) · Diabetes (5) · Heart Failure (4) · Obesity (3) · Migraine (2) · Type 2 Diabetes (1)
Get alerts when China National Center for Cardiovascular Diseases's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.